INTRODUCTION: THE ROLE OF NNOS IN CROSS TOLERANCE OF MORPHINE AND BUPIVACAINE IS NOT UNDERSTOOD.METHODS: MALE WISTAR RATS WEIGHT 200 TO 250 GRAMS WERE USED. THE SPINAL CANOLA IMPLANTED. THEN INTERATHECAL MORPHINE 5MG/KG, 3 TIMES A DAY, FOR 5 DAYS WAS INJECTED. TO INVESTIGATE TOLERANCE INDUCTION FORMALINE TEST WAS PERFORMED AT 5THDAY. IN ORDER TO STUDY THE CROSS TOLERANCE OF BUPIVACAINE AND MORPHINE, 20 MIN. AFTER THE LAST MORPHINE INJECTION AT 5TH DAY, BUPIVACAINE 5MG/KG WAS INTERATHECALY INJECTED, THEN FORMALINE TEST WAS PERFORMED. IN ANOTHER SERIES OF EXPERIMENTS, 20 MINUTES AFTER LAST MORPHINE INJECTION AT 5TH DAY, BUPIVACAINE INJECTED AND THEN AFTER 20 MINUTES, NNOS INHIBITOR (7-NI) 10 MG/ML WAS INJECTED AND AFTER 60 MINUTES, FORMALINE TEST WAS PERFOMED. AT 5TH DAY SPINAL CORD REMOVED AND EXPRESSION OF NNOS WAS STUDIED BY IMMUNOHISTOCHEMISTRY TECHNIQUE.RESULTS: THE RESULTS SHOWED THAT REPEATED INJECTION OF MORPHINE INDUCED TOLERANCE. BUPIVACAINE CUOLD NOT IMPROVE THE MORPHINE ANALGESIC EFFECT IN TOLERANT RATS. THE NNOS INHIBITOR, COULD REDUCE THE TOLERANCE TO ANALGESIC EFFECT MORPHINE ALONG BUPIVACAINE GROUP WHEN COMPARE TO MORPHINE GROUP (P<0.05).CONCLUSION: NNOS INHIBITION COULD REDUCE THE TOLERANCE TO ANALGESIC EFFECT OF MORPHINE, AND TOLERANCE TO ANALGESIC EFFECT OF MORPHINE ALONG TO BUPIVACAINE.